XZB-6877

N/A

Report date: 2023/06/15 13:36:56
NME

Base Information

Drug NameXZB-6877
Drug Alias NameXZB-6877
ClassificationSmall molecules
Mechanisms of ActionUpdating
TargetsUpdating
Therapy Area/IndicationsSmall Cell Lung CarcinomaOvarian NeoplasmsBreast Neoplasms
Global Approved IndicationsN/A
Approved Indications in ChinaN/A
Original Approved Country/TerritoryN/A
Original Approved DateN/A
Country/TerritoryMainland China
CombinationsNo
Global Highest StatusPreclinical
Highest Status in ChinaPreclinical
Originator CompaniesXuanzhu (Beijing) Pharm Co Ltd
China Registration ClassN/A

Develop Information

Active CompaniesXuanzhu (Beijing) Pharm Co Ltd
Inactive CompaniesN/A
Active IndicationsSmall Cell Lung CarcinomaOvarian NeoplasmsBreast Neoplasms
Inactive IndicationsN/A

Other Information

ATC CodeN/A
Related LinksN/A